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Tenofovir renal proximal tubular 
toxicity is regulated by OAT1 and 
MRP4 transporters
Kohler et al., Lab Invest 2011; 91: 852–858; doi:10.1038/labinvest.2011.48
Tenofovir disoproxil fumarate (TDF) is an oral prodrug and acyclic 
nucleotide analog of adenosine monophosphate that inhibits HIV-1 
(HIV) reverse transcriptase. A growing subset of TDF-treated 
HIV+ individuals presented with acute renal failure, suggesting 
tenofovir-associated kidney-specific toxicity. Previous studies using 
an HIV transgenic mouse model demonstrated specific changes in 
renal proximal tubular mitochondrial DNA (mtDNA) abundance. 
Nucleosides are regulated in biological systems via transport and 
metabolism in cellular compartments. Kohler et al. examined the 
roles of organic anion transporter type 1 (OAT1) and multidrug-
resistant protein type 4 (MRP4) in transport and regulation of 
tenofovir in proximal tubules. Renal toxicity was assessed in kidney 
tissues from OAT1 knockout (KO) or MRP4 KO compared with 
wild-type (WT, C57BL/6) mice following daily gavage with TDF 
(0.11 mg/d), didanosine (a related adenosine analog, 0.14 mg/d), 
or vehicle (0.1 M NaOH) for 5 weeks. Laser-capture microdis-
section was used to isolate renal proximal tubules for molecular 
analyses. mtDNA abundance and ultrastructural pathology were 
analyzed. The abundance of mtDNA in whole kidneys from 
both KO and WT mice was unchanged regardless of treatment. 
Renal proximal tubular mtDNA abundance in OAT1 KO mice 
also remained unchanged, suggesting prevention of TDF toxicity 
due to loss of tenofovir transport into proximal tubules. In con-
trast, renal proximal tubules from MRP4 KO exhibited increased 
mtDNA abundance following TDF treatment compared with WT 
littermates, suggesting compensation. Renal proximal tubules from 
TDF-treated WT and MRP4 KO mice exhibited increased num-
bers of irregular mitochondria with sparse, fragmented cristae in 
comparison with OAT1 KO. Treatment with didanosine had a 
compensatory effect on mtDNA abundance in OAT1 KO but not 
in MRP4 KO mice. Both OAT1 and MRP4 have a direct role in 
transport and efflux of tenofovir, regulating levels of tenofovir in 
proximal tubules. Disruption of OAT1 activity prevents tenofovir 
toxicity, but loss of MRP4 can lead to increased renal proximal 
tubular toxicity (Figure). These data help to explain mechanisms 
of human tenofovir renal toxicity. 
Marc De Broe
Effects of renal sympathetic 
denervation on glucose metabolism 
in patients with resistant 
hypertension: a pilot study
Mahfoud et al., Circulation 2011; 123: 1940–1946; doi:10.1161/
CIRCULATIONAHA.110.991869
Given the important role that renal sympathetic afferent and effer-
ent nerves play in blood pressure regulation, procedures such as 
radiofrequency ablation of those nerves have been investigated in 
the control of blood pressure. Because sympathetic overactivity has 
a mechanism similar to that of insulin resistance and hyperinsuline-
mia, Mahfoud et al. investigated the effect of renal denervation on 
glucose metabolism. Fifty patients with a blood pressure higher 
than 160 mm Hg despite treatment with at least three antihyper-
tensives participated. Patients had to have a glomerular filtration rate 
higher than 45 ml/min and could not have had renal artery stenosis, 
anatomic renal artery abnormalities, type 1 diabetes mellitus, or a 
recent major vascular event. Thirty-seven underwent the pro cedure 
initially, and the remaining 13 subjects constituted the control group 
to receive the procedure in 6 months. The procedure involves the 
introduction of a treatment catheter into each renal artery with 
subsequent provision of radiofrequency waves longitudinally and 
rotationally within the renal artery. The subjects were on average 
59.7 years old. Forty percent had type 2 diabetes mellitus, and the 
average systolic and diastolic pressures were 178 and 96 mm Hg, 
respectively, at baseline. The renal denervation group experienced 
a significantly reduced systolic and diastolic blood pressure at 1 
month, which was maintained until the end of the study (–28/–10 
at 1 month and –32/–12 at 3 months). The control patients saw a 
slight drop in blood pressure at 1 month and 3 months (–5/–3 at 3 
months), which did not reach significance. At 3 months, the group 
undergoing denervation saw a significant fall in fasting glucose 
from 118 ± 3.4 to 108 ± 3.8 mg/dl without significant changes in the 
control group. Similarly, insulin levels decreased from 20.8 ± 3.0 to 
9.3 ± 2.5 mIU/ml. Insulin sensitivity measured with homeostasis 
model assessment–insulin resistance (HOMA-IR) increased sig-
nificantly after renal denervation. This study demonstrates a role 
for the kidney in glucose metabolism and a therapeutic effect of the 
denervation procedure in the improvement of blood pressure con-
trol and insulin resistance. Before this procedure can be considered 
for widespread use, there are concerns to be addressed regarding the 
nature of the long-term effects, potential compensatory reactions 
after a period of 3 months that are not captured here, and the extent 
to which any benefit seen might be based on subgroups.
Lynda Szczech
Schematic diagram of mechanisms of OAT1 and MRP4 in the transport 
of antiretrovirals within renal proximal tubules. Abbreviations: ddI, 
didanosine; OA, organic anion; TFV, tenofovir.
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Location of ROMK (Kir1.1)  
in the distal nephron and its 
regulation by dietary K+
Wade et al., Am J Physiol Renal Physiol 2011; 300: F1385–F1393; doi:10.1152/
ajprenal.00592.2010
Current knowledge indicates that most urinary potassium enters 
the urine via the ROMK (Kir1.1) and BK (maxi-K) potassium 
channels. Knockout of the ROMK gene eliminates the most 
abundant potassium secretion in the collecting duct (CD), while 
knockout of BK a or other BK subunit genes attenuates the flow-
dependent kaliuretic response. Thus, the kidney has at least two 
separate potassium secretory pathways that together allow high-
capacity potassium excretion. ROMK channels are constitutively 
active and are believed to mediate basal potassium secretion, 
while the unique properties of the BK channels allow potassium 
secretion to be sensitive to the urinary flow rate. Activity of the 
ROMK channels is regulated by dietary potassium, increasing 
with loading and decreasing with restriction, but the mecha-
nism of this regulation is undefined. Because ROMK channels 
exhibit an open probability near unity, changes in their func-
tion are thought to be due to alterations in the density of open 
channels at the apical surface. In principle, this could occur by 
the switching of channel activity on and off, or by regulated 
channel trafficking such that channel abundance at the apical 
membrane changes. Micropuncture studies showed that potas-
sium secretion is principally regulated in the late distal nephron, 
including the distal convoluted tubule, the connecting tubule, 
and the initial portion of the CD, but ROMK analysis has so far 
focused on the CD, because it is the most amenable to patch 
clamping. Indeed, the exact location of ROMK in potassium-
secreting segments other than the CD is unresolved, partially 
because of the absence of highly specific and effective ROMK 
antibodies. Wade et al. exploited the availability of ROMK 
knockout mice to develop such specific antibodies, characterize 
the location of ROMK along the distal nephron, and examine its 
responses to variable potassium intake. They found that ROMK 
is more widely expressed along the entire distal nephron than 
previously thought, localizing to the distal convoluted tubule, 
the connecting tubule, and the cortical CD. At each tubular seg-
ment, ROMK was diffusely distributed both in the intracellular 
compartment and at the apical membrane, and in most loca-
tions, apical expression was significantly increased by a high-
potassium diet (Figure). The study thus characterizes ROMK 
localization along the entire distal nephron and shows that a 
high-potassium diet causes large increases in the apical expres-
sion of the channel.
Juan Oliver
Novel role for mTOR  
in diabetic nephropathy
Gödel et al., J Clin Invest 2011; 121: 2197–2209; doi:10.1172/JCI44774
Inoki et al., J Clin Invest 2011; 121: 2181–2196; doi:10.1172/JCI44771
Podocyte dysfunction is a critical event associated with 
proteinuria and glomerulosclerosis, including in diabetic 
nephropathy (DN). Two groups now report in side-by-side 
articles in the Journal of Clinical Investigation that mTOR may 
be involved in DN. It is known that the selective mTORC1 
inhibitor rapamycin can cause proteinuria in both humans and 
animal models of kidney disease, but it also has been shown to 
ameliorate some glomerular disease. Gödel et al. and Inoki et 
al. now report that tightly controlled mTOR activity is crucial 
to maintaining glomerular podocyte function, while dysregula-
tion of mTOR facilitates glomerular diseases. Genetic deletion 
of mTOR complex 1 (mTORC1) in mouse podocytes induced 
proteinuria and progressive glomerulosclerosis. Furthermore, 
simultaneous deletion of both mTORC1 and mTORC2 from 
mouse podocytes aggravated the glomerular lesions, revealing 
the importance of both mTOR complexes for podocyte home-
ostasis. In contrast, increased mTOR activity accompanied DN. 
Both groups also report that curtailing mTORC1 signaling in 
podocytes prevented glomerulosclerosis and significantly amel-
iorated the progression of glomerular disease in mice with DN. 
These results indicate that mTORC1 activation in podocytes is 
a critical event in DN and suggest that reduction of podocyte 
mTORC1 activity may be a potential therapeutic strategy to 
prevent progressive DN. As rapamycin has a number of other 
effects, including immunosuppression and changes in wound 
healing, much work will have to be done to test the feasibility 
and potential of this novel and exciting approach for DN.
Detlef Schlöndorff
Apical localization of ROMK in the collecting duct (CD). The apical 
membrane marker ezrin (red) and ROMK (green) had little overlap 
(yellow) at the apical surface in the CDs of animals on a low-potassium 
diet but had strong overlap (yellow) in the CDs of animals on a high-
potassium diet.
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